Rigon, L.; Salvalaio, M.; Pederzoli, F.; Legnini, E.; Duskey, J.T.; D’Avanzo, F.; De Filippis, C.; Ruozi, B.; Marin, O.; Vandelli, M.A.;
et al. Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles. Int. J. Mol. Sci. 2019, 20, 2014.
https://doi.org/10.3390/ijms20082014
AMA Style
Rigon L, Salvalaio M, Pederzoli F, Legnini E, Duskey JT, D’Avanzo F, De Filippis C, Ruozi B, Marin O, Vandelli MA,
et al. Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles. International Journal of Molecular Sciences. 2019; 20(8):2014.
https://doi.org/10.3390/ijms20082014
Chicago/Turabian Style
Rigon, Laura, Marika Salvalaio, Francesca Pederzoli, Elisa Legnini, Jason Thomas Duskey, Francesca D’Avanzo, Concetta De Filippis, Barbara Ruozi, Oriano Marin, Maria Angela Vandelli,
and et al. 2019. "Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles" International Journal of Molecular Sciences 20, no. 8: 2014.
https://doi.org/10.3390/ijms20082014
APA Style
Rigon, L., Salvalaio, M., Pederzoli, F., Legnini, E., Duskey, J. T., D’Avanzo, F., De Filippis, C., Ruozi, B., Marin, O., Vandelli, M. A., Ottonelli, I., Scarpa, M., Tosi, G., & Tomanin, R.
(2019). Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles. International Journal of Molecular Sciences, 20(8), 2014.
https://doi.org/10.3390/ijms20082014